Provided by Tiger Fintech (Singapore) Pte. Ltd.

TherapeuticsMD

1.25
+0.205019.62%
Post-market: 1.18-0.0700-5.60%19:58 EDT
Volume:8.76M
Turnover:12.45M
Market Cap:14.47M
PE:-29.34
High:1.70
Open:1.07
Low:1.05
Close:1.05
52wk High:2.44
52wk Low:0.7000
Shares:11.57M
Float Shares:9.56M
Volume Ratio:401.89
T/O Rate:91.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0426
EPS(LYR):-0.1891
ROE:-1.98%
ROA:-3.61%
PB:0.53
PE(LYR):-6.61

Loading ...

Company Profile

Company Name:
TherapeuticsMD
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
1
Office Location:
951 Yamato Road,Suite 220,Boca Raton,Florida,United States
Zip Code:
33431
Fax:
- -
Introduction:
LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

Directors

Name
Position
Tommy G. Thompson
Chairman of the Board
Cooper C. Collins
Director
Gail K. Naughton
Director
Justin Roberts
Director

Shareholders

Name
Position
Marlan D. Walker
Chief Executive Officer
Joseph Ziegler
Principal Financial and Accounting Officer